Time-dependent changes in hypoxia- and gliosis-related factors in experimental diabetic retinopathy.
Analysis of Variance
Animals
Biomarkers
/ metabolism
Blotting, Western
Diabetes Mellitus, Experimental
/ metabolism
Diabetic Retinopathy
/ metabolism
Gliosis
/ metabolism
Hypoxia
/ metabolism
Hypoxia-Inducible Factor 1, alpha Subunit
/ metabolism
Male
Rats
Rats, Sprague-Dawley
Receptors, Erythropoietin
/ metabolism
Vascular Endothelial Growth Factor A
/ metabolism
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
27
03
2018
accepted:
30
08
2018
revised:
21
08
2018
pubmed:
8
11
2018
medline:
14
8
2019
entrez:
8
11
2018
Statut:
ppublish
Résumé
Diabetes causes various biochemical changes in the retina; long-term changes in the factors associated with hypoxia and gliosis have rarely been reported. The present study was conducted to explore the changes in these factors in a time-dependent manner in experimental diabetic retinopathy (DR). Diabetes was induced in Sprague-Dawley rats by intraperitoneal injection of streptozotocin. The expression of the following factors was examined using immunofluorescence and western blot analysis at 0.5, 1, 2, 4 and 6 months after diabetes onset: hypoxia-inducible factor-1alpha (HIF-1alpha), vascular endothelial growth factor (VEGF), erythropoietin (EPO), erythropoietin receptor (EPOR), glial fibrillary acidic protein (GFAP), vimentin, glutamate-aspartate transporter (GLAST) and glutamine synthase (GS). The expression of factors such as HIF-1alpha, VEGF, EPO, EPOR, GFAP and vimentin, was up-regulated with the progression of diabetes in the diabetic rat retinas compared to the expression in normal control retinas, whereas the expression of GS and GLAST was down-regulated. Changes in EPO and EPOR appeared 2 weeks after diabetes onset. HIF-1alpha, VEGF and GFAP started to increase at 1 month and vimentin at 4 months after diabetes onset. GS and GLAST started to decrease at 1 month after diabetes onset. The expression of these factors, which are involved in the processes of hypoxia and gliosis, varied at different stages of DR. The time-course change may be helpful in the evaluation of the progression of DR, and it may indicate the optimal intervention time points for DR.
Identifiants
pubmed: 30401898
doi: 10.1038/s41433-018-0268-z
pii: 10.1038/s41433-018-0268-z
pmc: PMC6461831
doi:
Substances chimiques
Biomarkers
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Receptors, Erythropoietin
0
Vascular Endothelial Growth Factor A
0
Types de publication
Journal Article
Langues
eng
Pagination
600-609Références
Blood. 1999 Apr 15;93(8):2627-36
pubmed: 10194442
Invest Ophthalmol Vis Sci. 2000 Jun;41(7):1971-80
pubmed: 10845624
Nat Neurosci. 2000 Sep;3(9):873-80
pubmed: 10966617
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3561-8
pubmed: 11006253
J Biol Chem. 2001 Mar 23;276(12):9519-25
pubmed: 11120745
Neurochem Int. 2001 Apr;38(5):385-90
pubmed: 11222918
Curr Eye Res. 2001 Oct;23(4):276-84
pubmed: 11852429
Eye (Lond). 2002 May;16(3):242-60
pubmed: 12032713
Exp Eye Res. 2002 May;74(5):615-25
pubmed: 12076083
Circ Res. 2002 Jul 12;91(1):38-45
pubmed: 12114320
Microvasc Res. 2002 Sep;64(2):326-33
pubmed: 12204656
Surv Ophthalmol. 2002 Dec;47 Suppl 2:S253-62
pubmed: 12507627
Diabetes. 2003 Feb;52(2):506-11
pubmed: 12540628
N Engl J Med. 2004 Jan 1;350(1):48-58
pubmed: 14702427
Drug Discov Today. 2004 Aug 15;9(16):704-11
pubmed: 15341784
Exp Cell Res. 2004 Oct 1;299(2):476-85
pubmed: 15350545
Mol Vis. 2004 Aug 26;10:608-17
pubmed: 15354084
Neurosci Lett. 2005 Feb 21;374(3):179-82
pubmed: 15663958
N Engl J Med. 2005 Aug 25;353(8):782-92
pubmed: 16120858
Diabetes Care. 2005 Sep;28(9):2252-4
pubmed: 16123502
Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):531-8
pubmed: 16144690
Cancer Lett. 2005 Dec 8;230(1):122-33
pubmed: 16253768
Diabetes. 2006 Sep;55(9):2401-11
pubmed: 16936187
Br J Ophthalmol. 2007 Jun;91(6):822-6
pubmed: 17229797
Br J Pharmacol. 2007 Apr;150(7):823-5
pubmed: 17351666
Curr Eye Res. 2007 Mar;32(3):233-9
pubmed: 17453943
Strahlenther Onkol. 2007 Jul;183(7):366-73
pubmed: 17609869
J Clin Invest. 2008 Feb;118(2):526-33
pubmed: 18219389
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):726-31
pubmed: 18235021
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42
pubmed: 18235022
Diabetes Care. 2008 Jun;31(6):1189-94
pubmed: 18332162
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1329-35
pubmed: 18952918
Exp Eye Res. 2009 Dec;89(6):967-71
pubmed: 19699197
Am J Ophthalmol. 2009 Dec;148(6):883-9
pubmed: 19837381
Front Biosci (Elite Ed). 2011 Jan 01;3:201-11
pubmed: 21196299
Cell Mol Life Sci. 2012 Jan;69(1):115-28
pubmed: 21617913
Front Biosci (Elite Ed). 2011 Jun 01;3:1541-55
pubmed: 21622158
Chin Med Sci J. 2011 Jun;26(2):69-76
pubmed: 21703113
Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):199-201
pubmed: 22402950
Acta Ophthalmol. 2014 Jun;92(4):323-7
pubmed: 23718695
Clin Interv Aging. 2013;8:467-83
pubmed: 23766636
Int J Med Sci. 2013 Aug 22;10(10):1412-21
pubmed: 23983604
Trends Endocrinol Metab. 2014 Jan;25(1):23-33
pubmed: 24183659
Invest Ophthalmol Vis Sci. 2014 Mar 13;55(3):1519-30
pubmed: 24508793
PLoS One. 2014 Apr 02;9(4):e93433
pubmed: 24695675
Am J Pathol. 2014 Jun;184(6):1752-62
pubmed: 24709590
Biomed Res Int. 2014;2014:801269
pubmed: 25105142
Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2773-82
pubmed: 25813994
Biomed Pharmacother. 2015 Aug;74:145-7
pubmed: 26349976
Ophthalmologica. 2016;235(1):34-41
pubmed: 26630400
Nat Rev Endocrinol. 2016 Mar;12(3):130-1
pubmed: 26794438
Br J Ophthalmol. 2016 Dec;100(12):1611-1616
pubmed: 26951773
Rom J Ophthalmol. 2016 Jan-Mar;60(1):9-13
pubmed: 27220225
J Curr Ophthalmol. 2016 Mar 30;28(1):5-11
pubmed: 27239595
JAMA Ophthalmol. 2016 Aug 1;134(8):888-96
pubmed: 27280850
Neurobiol Dis. 2016 Nov;95:82-92
pubmed: 27425889
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H738-49
pubmed: 27473938
J Curr Glaucoma Pract. 2016 May-Aug;10(2):39-48
pubmed: 27536046
Ophthalmol Ther. 2017 Jun;6(1):33-47
pubmed: 28324452
Ophthalmology. 2017 May;124(5):619-633
pubmed: 28341474
Cochrane Database Syst Rev. 2017 Jun 22;6:CD007419
pubmed: 28639415
Diab Vasc Dis Res. 2018 May;15(3):214-222
pubmed: 29409329
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3974-8
pubmed: 8171022
Cancer Res. 1993 Aug 1;53(15):3624-31
pubmed: 8339269
Am J Physiol. 1998 Oct;275(4):L818-26
pubmed: 9755115